Mutated BRAF exerts exquisite control over MITF, which regulates the expression of key cell cycle facilitators, such as CDK2 and CDK4, stimulating melanoma cell proliferation, survival, and phenotype switching from proliferative and invasive states [5, 31]. The gene discussed is CDK2; the disease is melanoma.